Praxis Precision Medicines I (PRAX) Technical Analysis
$42.00▲3.83%
Market is closed - opens 7 PM, 17 Sep 2025
Insights
- Praxis Precision Medicines I is currently in a neutral trading position according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for Praxis Precision Medicines I stock suggests that it is range bound and no decision can be made based on this information
- Based on analysis of the Moving Averages technical indicator, Praxis Precision Medicines I stock is in a downtrend↘️
- Based on analysis of the Pivot Points, the current market trend for Praxis Precision Medicines I stock suggests that it is a good time to buy
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 43.27 | Neutral |
Stochastic | 40.97, 24.36 | Neutral |
Ultimate Oscillator | 58.37 | Neutral |
Stochastic Relative Strength Index | 42.18, 20.05 | Neutral |
Moving Average Convergence Divergence | -2.26, -1.91 | Neutral |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 42.01 | Sell |
20 | 44.18 | Sell |
50 | 48.7 | Buy |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 41.75 | Sell |
20 | 43.64 | Sell |
50 | 45.59 | Buy |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 41.22 | Neutral |
20 | 43.23 | Neutral |
50 | 48.89 | Sell |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 39.79 | Sell |
20 | 40.7 | Sell |
50 | 45.42 | Sell |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 39.69 | Buy |
20 | 39.36 | Sell |
50 | 42.56 | Sell |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 44.94 |
Resistance L2 | 42.76 |
Resistance L1 | 41.61 |
Pivot Point | 39.42 |
Support L1 | 38.27 |
Support L2 | 36.09 |
Support L3 | 34.94 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.